For example, in liposarcoma, leiomyosarcoma, synovial sarcoma, and fibrosarcoma, the Wnt/β-catenin signaling pathway is known to be constitutively activated, leading to enhanced proliferation and viability, with CDC25A identified as a key target gene (44, 45). Here, CDC25A is linked to synovial sarcoma.